Navigation Links
Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Date:9/11/2007

PT. RICHMOND, Calif., Sept. 11 /PRNewswire/ -- Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs, today announced that Glenn A. Oclassen, President and Chief Executive Officer is scheduled to present at the UBS 2007 Global Life Sciences Conference at the Grand Hyatt, New York, NY, on Tuesday, September 25, 2007 at 4:00 p.m. ET.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. The company's development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. Transcept's lead compound, Intermezzo(TM) (zolpidem tartrate lozenge), is a low dose formulation of zolpidem that is currently in late phase 3 clinical trials for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. TO-2060 is a novel, fixed-combination dose of olanzapine and ondansetron that is being evaluated for the treatment of dopamine associated psychiatric disorders (DAPD). TO-2060 is currently the subject of an initial proof of concept trial in the treatment of alcohol use disorder (AUD). For more information, please visit the Company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill Investors - Media

Director of Communications Stephanie Carrington/Jason Rando

(510) 215-3575 (646) 536-7017 ext. 7025

scarrington@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...rying of biopharmaceuticals to be available at the..., Toronto, ON (PRWEB) Nove...of Therapure Biopharma Inc. today announced that t...e pharmaceutical grade freeze dryer and expects to...on) available for contract manufacturing of biopha...
(Date:11/8/2009)...the battle is won," said Dr. Charmaine Yoest. ,...n a vote of 240-194, the Stupak-Ellsworth-Pitts-Ka...it abortion mandates and funding in HR 3962 passed...fe Action President and CEO Dr. Charmaine Yoest sa...r the pro-life Americans across this country who h...
(Date:11/8/2009)...H.R. 3961 to Secure the Stability of Medicare ,...ement Attributable to: J. James Rohack, M.D., Pres... http://www.newscom.com/cgi-bin/prnh/20081209/AMA...ouse health reform bill, which will help improve t...alls for swift passage of H.R. 3961 to secure the ...
(Date:11/8/2009)...of Health Care Reform Bill ,, Critical legisl...for all Americans ,, BALTIMORE, Nov. 7 /PRNews...States House of Representatives passed critical he... Medicare for seniors and end discrimination by in...s out of affordable health coverage. ,, The Aff...
(Date:11/7/2009)...-USNewswire/ -- The American Medical Association (...r Citizenship and Community Service to Manus C. Kr...e award recognizes physicians who have gone above ... an outstanding public service contribution to the...oday during the opening session of the 2009 Interi...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
... General Hospital Lawsuit , , VANCOUVER, May 21 /... TSX: QLT) announced that on May 21, 2009, the Dis...sued an oral ruling on QLT,s Motion to Dismiss all...l decision, the District Court dismissed all of th...
... Action to Improve Delivery of PMTCT , , GENEVA, ...headquarters in Geneva, members of the Internation...S-Free World met with the leaders and approximatel...on and Women,s Health, which identifies the failu...
... care practitioner, Trina Hammack knew the statist...r, she knew her prognosis was bleak. Fortunately,...ring effective new treatments for ovarian cancer. ...native treatments. , , Hammack owns Cornerstone W...
...ticals, Inc. (OTC: IMMP) announced today that the ...on the Pink OTC Markets quotation system on or abo...MMP". , , As announced previously, on March 27, 2...e Corporate Compliance Department of NYSE Regulati...
...rses Back To Job Market , , BERKELEY, Calif., May...hospitals -- a result of the economic recession --...eloras Jones, RN, MS, executive director of the Ca...actor in the job market for registered nurses (RNs...
...tering, which experts prefer , , THURSDAY,...ne while people are asleep, not only frees up time...r health as well, a new study suggests. , Although... done while a person sleeps. , "The concept is sim...
Other Medicine News:Health News:QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court 2Health News:QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court 3Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 3Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:Immtech to be Listed on OTC Market 2Health News:Hard Times for Nursing Hires Doesn't Signal End to Shortage According to California Institute for Nursing & Health Care 2Health News:Sleeping Through Dialysis May Be the Way to Go 2Health News:Sleeping Through Dialysis May Be the Way to Go 3
(Date:11/6/2009)... 6 NexBio Inc., in collaboration w...and Prevention (CDC), St. Louis University, and th...lication of two articles in the peer-reviewed jour... that DAS181 (Fludase ® ) may play a potentia...n of the Pandemic Influenza A(H1N1) and drug-resis...
(Date:11/6/2009)...mber 6 , - Trial Will Com...the,Treatment of Multi-Resistant Staphylococcus Au...ality pharmaceutical company focused on the discov...to overcome the significant global,problem of micr...vanced oral,antibacterial NXL103 (flopristin/linop...
(Date:11/5/2009)... Calif., Nov. 5 Transcep...lty pharmaceutical company focused on the developm...that address important therapeutic needs in the fi...a webcast and teleconference with management to di...sday, November 12, 2009, at 5:00 p.m. Eastern Stan...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 1Pharmacyclics Inc Rights Offering Oversubscribed 13381 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 3Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2
...ement Studied in Largest-Ever IVF Trial,in US, RAN... Results of,four studies evaluating Ferring Pharma...inal insert in development for luteal phase,suppor...tion and,the early stages of pregnancy) in assiste...t the 55th Annual Meeting of the,Pacific Coast Rep...
...NESS WIRE)--Apr 18, 2007 - Avanir,Pharmaceuticals ...sults from the company,s Phase III clinical trial ...xtromethorphan,hydrobromide/quinidine sulfate ("DM...iabetic neuropathic pain., The primary endpoint of...r the Pain Rating Scale as defined in the Special,...
Other Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: